A detailed history of Black Rock Inc. transactions in Chimerix Inc stock. As of the latest transaction made, Black Rock Inc. holds 906,551 shares of CMRX stock, worth $834,026. This represents 0.0% of its overall portfolio holdings.

Number of Shares
906,551
Previous 1,014,385 10.63%
Holding current value
$834,026
Previous $1.08 Million 25.86%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$0.87 - $1.05 $93,815 - $113,225
-107,834 Reduced 10.63%
906,551 $797,000
Q1 2024

May 10, 2024

SELL
$0.91 - $1.26 $29,089 - $40,278
-31,967 Reduced 3.06%
1,014,385 $1.08 Million
Q4 2023

Feb 13, 2024

SELL
$0.9 - $1.06 $3,720 - $4,382
-4,134 Reduced 0.39%
1,046,352 $1 Million
Q3 2023

Nov 13, 2023

SELL
$0.94 - $1.23 $89,826 - $117,538
-95,560 Reduced 8.34%
1,050,486 $1.01 Million
Q2 2023

Aug 11, 2023

SELL
$1.1 - $1.54 $4.11 Million - $5.76 Million
-3,739,363 Reduced 76.54%
1,146,046 $1.39 Million
Q1 2023

May 12, 2023

SELL
$1.19 - $2.09 $173,095 - $304,007
-145,458 Reduced 2.89%
4,885,409 $6.16 Million
Q4 2022

Feb 13, 2023

SELL
$1.67 - $2.35 $1.22 Million - $1.72 Million
-733,211 Reduced 12.72%
5,030,867 $9.36 Million
Q3 2022

Nov 14, 2022

SELL
$1.81 - $2.76 $26,331 - $40,152
-14,548 Reduced 0.25%
5,764,078 $11.1 Million
Q2 2022

Aug 12, 2022

BUY
$1.34 - $5.34 $575,642 - $2.29 Million
429,584 Added 8.03%
5,778,626 $12 Million
Q1 2022

May 12, 2022

SELL
$4.58 - $6.8 $147,448 - $218,919
-32,194 Reduced 0.6%
5,349,042 $24.5 Million
Q4 2021

Feb 10, 2022

BUY
$5.23 - $7.18 $2.34 Million - $3.22 Million
447,818 Added 9.08%
5,381,236 $34.6 Million
Q3 2021

Nov 09, 2021

SELL
$5.94 - $8.75 $140,302 - $206,675
-23,620 Reduced 0.48%
4,933,418 $30.5 Million
Q2 2021

Aug 11, 2021

BUY
$7.54 - $9.79 $37.4 Million - $48.5 Million
4,957,038 New
4,957,038 $39.7 Million

Others Institutions Holding CMRX

About CHIMERIX INC


  • Ticker CMRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,622,896
  • Market Cap $80.6M
  • Description
  • Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...
More about CMRX
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.